Katja Harbst
11 – 20 of 38
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
- Contribution to journal › Article
-
Mark
Qualitative analysis of tumor-infiltrating lymphocytes across human tumor types reveals a higher proportion of bystander CD8+ T cells in non-melanoma cancers compared to melanoma
- Contribution to journal › Article
-
Mark
CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer
- Contribution to journal › Article
- 2019
-
Mark
The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma
- Contribution to journal › Article
- 2018
-
Mark
The genetic evolution of melanoma
(2018) p.105-114
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2017
-
Mark
Acquired immune resistance follows complete tumor regression without loss of target antigens or IFNγ signaling
- Contribution to journal › Article
-
Mark
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
- Contribution to journal › Article
-
Mark
NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics
- Contribution to journal › Article
- 2016
-
Mark
Multiregion whole-exome sequencing uncovers the genetic evolution and mutational heterogeneity of early-stage metastatic melanoma
- Contribution to journal › Article
- 2015
-
Mark
DNA methylation subgroups in melanoma are associated with proliferative and immunological processes.
- Contribution to journal › Article
